MindMics Alpha test

In order to join the MindMics early product test, we’ll need your shipping address, and we’ll also need you to read and agree to the Research Consent Terms and the NDA terms.

Research Consent Terms and Non-Disclosure Agreement Early Product Test, MindMics, Inc.

RESEARCH CONSENT TERMS

Purpose of Study
You are being asked to take part in an early product research study. Before you decide to participate in this study, it is important that you understand why the research is being done and what it will involve. Please read the following information carefully. Please ask MindMics, Inc. if there is anything that is not clear or if you need more information.  You can reach us via email at team@mindmics.com.

The purpose of this study is to help us learn more about how MindMics performs during common, everyday activities.

Study Procedures

  • Before the study begins, we will ask you to electronically sign and submit the Non-Disclosure Agreement and agree to these Research Consent Terms. 

  • We will ship you a MindMics product before the start of testing on June 27.  The test will then run two months until Monday, August 22.

  • You should review the quick start guide as you begin the early product test program.

  • We will ask you to set up your MindMics system on Monday, June 27.  This should take no more than 30 minutes.  There will be included instructions for set-up and we expect that this will be easy to do on your own.  However, Chat or email support will be available if needed.

  • You should be comfortable wearing earbuds for a few hours at a time as part of your daily routine.  Please be assured that the MIndMics earbuds will work well for your regular listening needs.

  • You should be comfortable downloading and installing apps on your phone.

  • You must ensure that the product is charged and available for daily use.

  • During the test, we will regularly email you to ask you to wear your MIndMics earbuds during a specific type of activity that you would ordinarily be doing.  Examples might include going on a walk, participating in a Zoom call, cleaning, etc. We will then ask you to answer a short, online questionnaire about these specific activities.

  • At the end of the test, you will be asked to ship back the product using a prepaid shipping label that we will provide.

Risks
There are no foreseeable risks for your participation in this study. You may decline to answer any or all questions and you may terminate your involvement at any time if you choose.

Benefits
There will be no direct benefit to you for your participation in this study. However, we hope that the information obtained from this study may help MindMics to continue to improve the quality of its data collection.

Confidentiality

We maintain confidentiality of participant’s personal data and keep it secure. We store only those portions of the personal data that will allow us to contact the participants for planned research sessions and for future studies, and we delete all other personal data upon conclusion of the study. We store research data obtained during the research study, but it is anonymized and thus not connected to the participants or their personal data in any way.

Compensation

Participants who meet all product testing expectations will receive a total of $175 in Amazon gift certificates, distributed over two months during the testing period.

  • Participants who complete their weekly surveys will receive two $50 Amazon gift certificates — one at the end of week four and another at the end of week eight.

  • Once MindMics receives the earbuds at the conclusion of the trial period, participants will then receive their third and final payment, a $75 Amazon gift certificate.

Contact Information
If you have questions at any time about this study you may contact the research team at team@mindmics.com.

Voluntary Participation
Your participation in this study is voluntary. It is up to you to decide whether or not to take part in this study. When you decide to take part in this study, we ask that you sign this consent form. After you sign the consent form, you are still free to withdraw at any time and without giving a reason. Withdrawing from this study will not affect the relationship you have, if any, with MindMics, Inc.If you withdraw from the study before data collection is completed, your data will be returned to you or destroyed.

NDA

This Non-Disclosure Agreement (this “Agreement”) is entered into between MindMics, Inc., a Massachusetts corporation (the “Company”) and the recipient named on the signature page hereto (the “Recipient”) as of the date signed below (the “Effective Date”), to protect the confidentiality of certain confidential information of the Company to be disclosed to the Recipient solely for use in evaluating or pursuing a business relationship with the Company (the “Permitted Use”).

1. As used herein, “Confidential Information” will mean any and all technical and non-technical information provided by the Company to the Recipient, which may include without limitation information regarding: (a) patent and patent applications; (b) trade secrets; (c) proprietary and confidential information, ideas, techniques, sketches, drawings, works of authorship, models, inventions, know-how, processes, apparatuses, equipment, algorithms, software programs, software source documents, and formulae related to the current, future, and proposed products and services of the Company, including without limitation the Company’s information concerning research, experimental work, development, design details and specifications, engineering, financial information, procurement requirements, purchasing, manufacturing, customer lists, investors, employees, business and contractual relationships, business forecasts, sales and merchandising, marketing plans and information the Company provides regarding third parties; and (d) all other information that the Recipient knew, or reasonably should have known, was the Confidential Information of the Company.

2. Subject to Section 3, the Recipient agrees that at all times and notwithstanding any termination or expiration of this Agreement it will hold in strict confidence and not disclose to any third party any Confidential Information, except as approved in writing by the Company, and will use the Confidential Information for no purpose other than the Permitted Use. The Recipient will also protect such Confidential Information with at least the same degree of care that the Recipient uses to protect its own Confidential Information, but in no case, less than reasonable care. The Recipient will limit access to the Confidential Information to only those of its employees or authorized representatives having a need to know and who have signed confidentiality agreements containing, or are otherwise bound by, confidentiality obligations at least as restrictive as those contained herein.

3. The Recipient will not have any obligations under this Agreement with respect to a specific portion of the Confidential Information if the Recipient can demonstrate with competent evidence that such Confidential Information:

(a) was in the public domain at the time it was disclosed to the Recipient;

(b) entered the public domain subsequent to the time it was disclosed to the Recipient, through no fault of the Recipient;

(c) was in the Recipient’s possession free of any obligation of confidence at the time it was disclosed to the Recipient;

(d) was rightfully communicated to the Recipient free of any obligation of confidence subsequent to the time it was disclosed to the Recipient; or

(e) was developed by employees or agents of the Recipient who had no access to any Confidential Information.

4. Notwithstanding the above, the Recipient may disclose certain Confidential Information, without violating the obligations of this Agreement, to the extent such disclosure is required by a valid order of a court or other governmental body having jurisdiction, provided that the Recipient provides the Company with reasonable prior written notice of such disclosure and makes a reasonable effort to obtain, or to assist the Company in obtaining, a protective order preventing or limiting the disclosure and/or requiring that the Confidential Information so disclosed be used only for the purposes for which the law or regulation required, or for which the order was issued.

5. The Recipient will immediately notify the Company in the event of any loss or unauthorized disclosure of any Confidential Information.

6. Upon termination or expiration of this Agreement, or upon written request of the Company, the Recipient will promptly return to the Company all documents and other tangible materials representing any Confidential Information and all copies thereof.

7. Confidential Information is and will remain the sole property of the Company. The Recipient recognizes and agrees that nothing contained in this Agreement will be construed as granting any property rights, by license or otherwise, to any Confidential Information disclosed under this Agreement, or to any invention or any patent, copyright, trademark, or other intellectual property right that has issued or that may issue, based on such Confidential Information. The Recipient will not make, have made, use or sell for any purpose any product or other item using, incorporating or derived from any Confidential Information. Neither this Agreement nor the disclosure of any Confidential Information hereunder will result in any obligation on the part of either party to enter into any further agreement with the other, license any products or services to the other, or to require the Company to disclose any particular Confidential Information. Nothing in this Agreement creates or will be deemed to create any employment, joint venture, or agency between the parties.

8. Confidential Information will not be reproduced in any form except as required to accomplish the intent of this Agreement. Any reproduction of any Confidential Information will remain the property of the Company and will contain any and all confidential or proprietary notices or legends that appear on the original, unless otherwise authorized in writing by the Company.

9. This Agreement will terminate five years after the Effective Date, or may be terminated by either party at any time upon 30 days written notice to the other party. The Recipient’s obligations under this Agreement will survive termination of this Agreement and will be binding upon the Recipient’s heirs, successors, and assigns. The Recipient’s obligations with respect to all Confidential Information will terminate only pursuant to Section 3.

10. THE COMPANY IS PROVIDING CONFIDENTIAL INFORMATION ON AN “AS IS” BASIS FOR USE BY THE RECIPIENT AT ITS OWN RISK. THE COMPANY DISCLAIMS ALL WARRANTIES, WHETHER EXPRESS, IMPLIED OR STATUTORY, INCLUDING WITHOUT LIMITATION ANY IMPLIED WARRANTIES OF TITLE, NON-INFRINGEMENT OF THIRD PARTY RIGHTS, MERCHANTABILITY, OR FITNESS FOR A PARTICULAR PURPOSE.

11. This Agreement and any action related thereto will be governed, controlled, interpreted, and defined by and under the laws of the State of Delaware, without giving effect to any conflicts of laws principles that require the application of the law of a different state. Any disputes under this Agreement may be brought in the state courts and the Federal courts for the county in which Company’s principal place of business is located, and the parties hereby consent to the personal jurisdiction and exclusive venue of these courts. This Agreement may not be amended except by a writing signed by both parties.

12. The Recipient hereby agrees that its breach of this Agreement will cause irreparable damage to the Company for which recovery of damages would be inadequate, and that the Company will be entitled to obtain timely injunctive relief under this Agreement, as well as such further relief as may be granted by a court of competent jurisdiction.

13. If any provision of this Agreement is found by a proper authority to be unenforceable or invalid, such unenforceability or invalidity will not render this Agreement unenforceable or invalid as a whole and, in such event, such provision will be changed and interpreted so as to best accomplish the objectives of such unenforceable or invalid provision within the limits of applicable law or applicable court decisions. Any waiver or failure to enforce any provision of this Agreement on one occasion will not be deemed a waiver of any other provision or of such provision on any other occasion.

14. The Recipient will not assign or transfer any rights or obligations under this Agreement without the prior written consent of the Company and any attempted assignment, subcontract, delegation, or transfer in violation of the foregoing will be null and void.

15. The Recipient will not export, directly or indirectly, any U.S. technical data acquired pursuant to this Agreement, or any products utilizing such data, in violation of the United States export laws or regulations.

16. All notices or reports permitted or required under this Agreement will be in writing and will be delivered by personal delivery, electronic mail, facsimile transmission or by certified or registered mail, return receipt requested, and will be deemed given upon personal delivery, five (5) days after deposit in the mail, or upon acknowledgment of receipt of electronic transmission. Notices will be sent to the addresses set forth at the end of this Agreement or such other address as either party may specify in writing.

17. The Recipient agrees that the software programs of the Company contain valuable confidential information and agrees that it will not modify, reverse engineer, decompile, create other works from, or disassemble any software programs contained in the Confidential Information without the prior written consent of the Company.

18. This Agreement is the final, complete and exclusive agreement of the parties with respect to the subject matters hereof and supersedes and merges all prior discussions between the parties with respect to such matters. No modification of or amendment to this Agreement will be effective unless in writing and signed by the party to be charged.

19. This Agreement may be executed in two or more counterparts, each of which will be deemed an original, but all of which together will constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act or other applicable law) or other transmission method and any counterpart so delivered will be deemed to have been duly and validly delivered and be valid and effective for all purposes.

The parties have executed this Non-Disclosure Agreement as of the Effective Date.

COMPANY: MindMics, Inc., 86 Sherman Street Cambridge, Massachusetts 02140

RECIPIENT:

The Research Consent Form and Non-Disclosure Agreement are both available as PDFs if you wish to download them for your records. If you have any questions, feel free to email them to team@mindmics.com.